Search results
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 2 weeks agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters· 2 weeks agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 2 days agoModerna stock analysts project $4.19 billion in full-year revenue, including $4.06 billion in sales...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown - ...
Benzinga· 2 weeks agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 2 weeks agoModerna’s Spikevax vaccine was the third jab to be approved for use in the UK in January 2021 after...
Moderna Litigation Against BioNTech and Pfizer Stayed Pending IPR | JD Supra
JD Supra· 5 days agoWe previously reported on the litigation brought by ModernaTX, Inc. and Moderna US, Inc. (collectively, “Moderna”) against BioNTech SE, BioNTech...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 1 week ago(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing...
U.S. to start offering COVID-19 vaccine booster doses in September
AOL· 6 days agoThe White House is prepared to offer a third booster shot starting on that date to all Americans who...
mRNA Is Promising A Breakthrough In Fighting Cancer
Benzinga via AOL· 5 days agoBy the looks of it, this was only the beginning of the healthcare revolution that mRNA triggered. Mainz Biomed...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 2 days agoModerna's first quarter net loss of $1.18 billion was also stronger than Wall Street expectations of...